218 related articles for article (PubMed ID: 23256951)
1. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis.
McErlane F; Beresford MW; Baildam EM; Chieng SE; Davidson JE; Foster HE; Gardner-Medwin J; Lunt M; Wedderburn LR; Thomson W; Hyrich KL;
Ann Rheum Dis; 2013 Dec; 72(12):1983-8. PubMed ID: 23256951
[TBL] [Abstract][Full Text] [Related]
2. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.
Nordal EB; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Peltoniemi S; Straume B; Rygg M
Ann Rheum Dis; 2012 Jul; 71(7):1122-7. PubMed ID: 22258487
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
Consolaro A; Ruperto N; Bazso A; Pistorio A; Magni-Manzoni S; Filocamo G; Malattia C; Viola S; Martini A; Ravelli A;
Arthritis Rheum; 2009 May; 61(5):658-66. PubMed ID: 19405003
[TBL] [Abstract][Full Text] [Related]
4. Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27.
Remthangpuii F; Maheshwari A; Gulati S; Sharma S; Mahto D; Chandra J
Indian J Pediatr; 2023 Dec; 90(12):1177-1181. PubMed ID: 36763251
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis].
Capela RC; Corrente JE; Magalhães CS
Rev Bras Reumatol; 2015; 55(1):31-6. PubMed ID: 25440705
[TBL] [Abstract][Full Text] [Related]
6. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.
Bulatović Calasan M; de Vries LD; Vastert SJ; Heijstek MW; Wulffraat NM
Rheumatology (Oxford); 2014 Feb; 53(2):307-12. PubMed ID: 24162034
[TBL] [Abstract][Full Text] [Related]
8. Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register.
Mourão AF; Santos MJ; Melo-Gomes J; Martins FM; Costa JA; Ramos F; Brito I; Duarte C; Figueira R; Figueiredo G; Furtado C; Lopes A; Oliveira M; Rodrigues A; Salgado M; Sousa M; Branco JC; Fonseca JE; Canhão H
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):585-91. PubMed ID: 25354266
[TBL] [Abstract][Full Text] [Related]
9. Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score.
Consolaro A; Ruperto N; Bracciolini G; Frisina A; Gallo MC; Pistorio A; Verazza S; Negro G; Gerloni V; Goldenstein-Schainberg C; Sztajnbok F; Wulffraat NM; Martini A; Ravelli A;
Ann Rheum Dis; 2014 Jul; 73(7):1380-3. PubMed ID: 24347571
[TBL] [Abstract][Full Text] [Related]
10. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis.
Selvaag AM; Aulie HA; Lilleby V; Flatø B
Ann Rheum Dis; 2016 Jan; 75(1):190-5. PubMed ID: 25362042
[TBL] [Abstract][Full Text] [Related]
11. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
[TBL] [Abstract][Full Text] [Related]
12. Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
Alexeeva EI; Namazova-Baranova LS; Bzarova TM; Valieva SI; Denisova RV; Sleptsova TV; Isaeva KB; Chomahidze AM; Taibulatov NI; Fetisova AN; Karaseva AV; Baranov AA
Pediatr Rheumatol Online J; 2017 Jun; 15(1):51. PubMed ID: 28615036
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.
El Gazzar II; Fathy HM; Gheita TA; Nour El-Din AM; Rasheed EA; Bassyouni RH; Kenawy SA
Clin Rheumatol; 2017 Aug; 36(8):1757-1763. PubMed ID: 28593608
[TBL] [Abstract][Full Text] [Related]
14. Disease activity assessment for juvenile idiopathic arthritis in transitional care.
La Torre F; Coppola C; Anelli MG; Cacciapaglia F; Lopalco G; Cardinale F; Iannone F
Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916167
[TBL] [Abstract][Full Text] [Related]
15. Association of hand grip strength with disease activity, disability and quality of life in children and adolescents with Juvenile Idiopathic Arthritis.
Rashed AM; Abdel-Wahab N; Moussa EMM; Hammam N
Adv Rheumatol; 2018 Jun; 58(1):11. PubMed ID: 30657067
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
[TBL] [Abstract][Full Text] [Related]
17. Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis.
Tibaldi J; Pistorio A; Aldera E; Puzone L; El Miedany Y; Pal P; Giri PP; De H; Khubchandani R; Chavan PP; Vilaiyuk S; Lerkvaleekul B; Yamsuwan J; Sabui TK; Datta P; Pardeo M; Bracaglia C; Sawhney S; Mittal S; Hassan WA; Elderiny GF; Abu-Zaid MH; Eissa M; Sztajnbok F; das Neves Sztajnbok FC; Russo R; Katsicas MM; Cimaz R; Marrani E; Alexeeva E; Dvoryakovskaya TM; Alsuweiti MO; Alzyoud RM; Kostik M; Chikova I; Minoia F; Filocamo G; Farag Y; Lotfy H; Nasef SI; Al-Mayouf SM; Maggio MC; Magalhaes CS; Gallizzi R; Conti G; Shimizu M; Civino A; Felici E; Giancane G; Ruperto N; Consolaro A; Ravelli A
Rheumatology (Oxford); 2020 Nov; 59(11):3505-3514. PubMed ID: 32829413
[TBL] [Abstract][Full Text] [Related]
18. How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
Shoop-Worrall SJW; Verstappen SMM; Baildam E; Chieng A; Davidson J; Foster H; Ioannou Y; McErlane F; Wedderburn LR; Thomson W; Hyrich KL
Ann Rheum Dis; 2017 Aug; 76(8):1381-1388. PubMed ID: 28389553
[TBL] [Abstract][Full Text] [Related]
19. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.
Raab A; Kallinich T; Huscher D; Foeldvari I; Weller-Heinemann F; Dressler F; Kuemmerle-Deschner JB; Klein A; Horneff G
Pediatr Rheumatol Online J; 2021 Mar; 19(1):41. PubMed ID: 33752685
[TBL] [Abstract][Full Text] [Related]
20. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
Funk RS; Chan MA; Becker ML
Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
